Edwards Lifesciences (EW) PT Lowered to $80 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Edwards Lifesciences (EW) PT Lowered to $80 at Barclays
September 9, 2024 6:54 AM EDTBarclays analyst Matt Miksic lowered the price target on Edwards Lifesciences (NYSE: EW) to $80.00 (from $90.00) while maintaining a Overweight rating.
The analyst comments "What to Do with the Stock Here? We expect increasing interest in EW as we approach TCT (Oct 27-31), given the two key clinical catalysts... More
Edwards Lifesciences (EW) PT Lowered to $80 at Barclays
September 9, 2024 6:54 AM EDTBarclays analyst Matt Miksic lowered the price target on Edwards Lifesciences (NYSE: EW) to $80.00 (from $90.00) while maintaining a Overweight rating.
The analyst comments "What to Do with the Stock Here? We expect increasing interest in EW as we approach TCT (Oct 27-31), given the two key clinical catalysts... More



